tbuckley/cabot-search huggingface dataset:
Single-Cell RNA-Sequencing of 6 Million Tumor and Immune Cells in 365 Patients with MGUS and SMM Demonstrates Complex Progressive Changes in Immune Cell Functionality with a Distinct Footprint on Tumor Cell Biology and Disease Control
Authors: Romanos Sklavenitis-Pistofidis, Ting Wu, Elizabeth D. Lightbody, Yoshinobu Konishi, Mahshid Rahmat, Michael P. Agius, Junko Tsuji, Jean-Baptiste Alberge, Michael Timonian, Ankit K. Dutta, Michelle P. Aranha, Nayda Bidikian, Hadley Barr, Nicholas J. Haradhvala, Moshe Sade-Feldman, Gad Getz, Irene Ghobrial
Journal: Blood (2024)
Iberdomide, Daratumumab, and Dexamethasone Shows Deep Antimyeloma Activity across Molecular Patient Subsets with Transplant-Ineligible Newly Diagnosed Multiple Myeloma from the CC-220-MM-001 Trial
Authors: Michael Amatangelo, Nicholas Stong, Paulo Maciag, Anna Sureda Balari, Niels W.C.J. van de Donk, Sagar Lonial, Anita K. Gandhi
Journal: Blood (2024)
4q Copy Neutral Loss of Heterozygosity and <i>KMT2A</i> Partial Tandem Duplication Identified By Chromosomal Genomic Array Testing (CGAT) Correlated with Decreased Overall Survival in Acute Myeloid Leukemia (AML)
Authors: Suravi Raychaudhuri, Ted Gooley, Megan Othus, Xiaoyu Qu, Carole Shaw, Kathryn Russell, Rutu D. Vyas, Jacob S. Appelbaum, Anna B. Halpern, Roland B. Walter, Harry P. Erba, Min Fang, Mary-Elizabeth M. Percival
Journal: Blood (2024)
Outcomes of Patients with Hodgkin Lymphoma Receiving Brentuximab Vedotin (BV) As Maintenance Therapy after ASCT According to Previous Exposure to BV. a Retrospective Analysis of the EBMT Lymphoma Working Party in Collaboration with Geltamo, FIL, Lysarc, and Turkish Lymphoma Group
Authors: Maria Carmen Martinez Munoz, Irma Khvedelidze, Mathilde Fekom, Benedicte Deau Fischer, Amira Marouf, Herve Ghesquieres, Luc-Matthieu Fornecker, Francesco Merli, Piero Maria Stefani, Fulvio Massaro, Barbara Botto, A. Burhan Ferhanoglu, Olga Meltem Akay, Murat Ozbalak, Manuel Espeso De Haro, Samuel Romero, Jaques-Emmanuel Galimard, Bertram Glass, Ali Bazarbachi, Anna Sureda Balari
Journal: Blood (2024)
TSUBASA Study: A Prospective Study Evaluating the Association between Physical Activity and Bleeding Events, Quality of Daily Life, and Safety in People with Hemophilia A without FVIII Inhibitors
Authors: Keiji Nogami, Teruhisa Fujii, Akihiro Sawada, Azusa Nagao, Chiai Nagae, Masanori Nojima, Nobuaki Suzuki, Mika Kawano, Tomomi Shimura, Yoshimasa Sugao, Kagehiro Amano
Journal: Blood (2024)
Patient-Reported Chemotherapy-Induced Peripheral Neuropathy (CIPN) in Advanced-Stage Classical Hodgkin Lymphoma Treated with BrECADD and eBEACOPP in the HD21 Trial
Authors: Fjoralba Kristo, Flora Mazerolle, Thibaud Alin, Antoine Regnault, Justin Ferdinandus, Karolin Behringer, Janina Jablonski, Peter Borchmann, Ajibade Ashaye
Journal: Blood (2024)
Novel Non-Coding Candidate Drivers of Multiple Myeloma Linked to Plasma Cell Tumor Biology and B Cell Development
Authors: Jean-Baptiste Alberge, Ankit K. Dutta, Andrea Poletti, Oliver Priebe, Tim H.H. Coorens, Elizabeth D. Lightbody, Rosa Toenges, Xavi Loinaz, Sofia Wallin, Andrew Dunford, Cody J. Boehner, Erica M. Horowitz, Nang Kham Su, Hadley Barr, Laura Hevenor, Katherine Towle, Rashmika Beesam, Jenna D. Beckwith, Jacqueline Perry, David M. Cordas dos Santos, Luca Bertamini, Kirsten Kübler, Carolina Terragna, Elena Zamagni, Julian Hess, Romanos Sklavenitis-Pistofidis, Chip Stewart, Gad Getz, Irene Ghobrial
Journal: Blood (2024)
Reduction in Platelet Counts May Predict the Development of Immune Effector Cell Associated Neurotoxicity Syndrome in Patients Receiving CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B Cell Lymphoma
Authors: Hazim Khatib, Amit Parizat, Jabour Halloun, Roni Shouval, Niveen Shibli, Onit Alalouf, Tsila Zuckerman, Nataly Vahaba, Iris Halamish, Danielle Sapir, Israel Henig, Dana Yehudai-Ofir, Shimrit Harlev, Netanel A. Horowitz, Noa Lavi, Nurit Horesh, Riva Fineman, Inna Tzoran, Tsofia Levi, Eldad J. Dann, Ahmad Mruwat, Benjamin Brenner, Ron Hoffman, Ayal Rozenberg, Yoav Shechtman, Ofrat Beyar-Katz
Journal: Blood (2024)
Practical Implications of Multi-Institution Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity (ICANS) Rates in Lymphoma Targeted Bispecific Antibodies (BsAb)
Authors: Sara Leidy, Jordan Snyder, James A Davis, William Wesson, Brian Hess, Ryan Jacobs, Madalyn Edmonds, Nausheen Ahmed, Marc Hoffmann
Journal: Blood (2024)
Ph-like ALL Is Associated with Unfavorable Outcomes in Hispanics and Native Americans: A Multicenter Analysis
Authors: Jessica Lewis-Gonzalez, Jonathon Cordova, Huining Kang, Cecilia Y. Arana Yi, Ahmed Ibrahim, Patricia Greipp, Anand Ashwin Patel, Muriel Battaglia, Anthony J. Perissinotti, Bernard Lawrence Marini, Martina Fraga, Dale Bixby, Kristen M. Pettit, Patrick W. Burke, Charles Foucar
Journal: Blood (2024)
Proteasome Shuttle Factor and DNA Repair Protein Rad23A Is a Potential Therapeutic Target in Multiple Myeloma
Authors: Xueping Wan, Yan Song, Ting Du, Arghya Ray, Teng Fang, Minxing Wang, Sindhu C Pillai, Md. Abu Musa, Kenneth Wen, Dharminder Chauhan, Kenneth C. Anderson
Journal: Blood (2024)
The Impacts of Circulating Lymphoblasts and the Day of the First Triple Intrathecal Therapy on the CNS Outcomes of Childhood ALL: The Report of Taiwan Pediatric Oncology Group (TPOG)-ALL-2013
Authors: Hsi-Che Liu, Shiann-Tarng Jou, Shih-Hsiang Chen, Tang-Her Jaing, Ting-Chi Yeh, Jiann-Shiuh Chen, Kang-Hsi Wu, Shih-Chung Wang, Chih-Cheng Hsiao, Te-Kau Chang, Meng-Yao Lu, Hsiu-Ju Yen, Fang-Liang Huang, Shu-Huey Chen, Shang-Hsien Yang, Yen-Lin Liu, Shyh-Shin Chiou, Chao-Ping Yang, Lee-Yung Shih, Dong-Tsamn Lin
Journal: Blood (2024)
The Mutational Landscape of Extramedullary Multiple Myeloma Reveals Novel Biologic Insights and Potential Therapeutic Targets for Exploration
Authors: Saurabh Zanwar, Joseph Novak, Michael D Howe, Moritz Binder, Wilson I. Gonsalves, Esteban Braggio, Vincent Rajkumar, Dragan Jevremovic, Surendra Dasari, Shaji Kumar
Journal: Blood (2024)
Influence of COVID-19 on Acute Myeloid Leukemia Treatment Efficacy: Insights from a Propensity Score-Matched Cohort Study
Authors: Aditya Sood, Anish Sangari, Jervon Wright, Margaret Locke, Joseph Elengickal, Lilly Hou, Wint Yan Aung, Adit Singhal, Riya George, Maria J Nieto
Journal: Blood (2024)
Allopurinol Add-on Treatment - Promising Approach to Opitimize Maintenance Therapy for Acute Lymphoblastic Leukemia in Children
Authors: Jonatan Källström, Riitta Niinimäki, Johan Fredlund, Hartmut Vogt, Laura Korhonen, Anders Castor, Kjeld Schmiegelow, Maria Thastrup, Jonas Abrahamsson, Torben Ek
Journal: Blood (2024)
A Phase I Dose Escalation and Expansion Trial of Lyt-200 (a First-In-Class Anti-Galectin-9 Antibody) Alone and in Combination with Venetoclax/HMA in Relapsed/Refractory AML/MDS
Authors: Amir T. Fathi, Aleksandra Filipovic, Keri Maher, Dale G Schaar, Rabin Niroula, Joseph J. Maly, Deepa Jaykumar, Noah Merin, Jay Yang, Jorge R. Galvez Silva, Varun Gang, Taylor Meeks, Christopher Korth, Guenther Koehne
Journal: Blood (2024)
Variation in Diagnostic Evaluation Patterns for Pediatric Evans Syndrome: Survey Results from the Pediatric ITP Consortium of North America (ICON)
Authors: Taylor Olmsted Kim, Kirsty Hillier, Elizabeth Gunn, Sherif M. Badawy, Amanda B. Grimes, Megan Gilbert, Allison Remiker, Stephanie A. Fritch Lilla, Shipra Kaicker, Michele P. Lambert, Rachael F. Grace, Deirdra R Terrell
Journal: Blood (2024)
Monocytic Differentiation in B-Lymphoblastic Leukemia with <i>CRLF2</i> rearrangement at Diagnosis: Implications for Pathogenesis and Post-Therapeutic Lineage Switch
Authors: Alexandra E. Kovach, Sara K. Silbert, Annie Luong, Gerald Lu, Michael Lu, Hao-Wei Wang, Karen M Chisholm, Andrew Doan, Deepa Bhojwani, Adam Lamble, Nirali N. Shah, Chintan Parekh, Gordana Raca, Brent L. Wood
Journal: Blood (2024)
Optimising the Duration of Therapy for Newly Diagnosed Transplant Ineligible Patients - Analysis of Long Term Follow up Data from the UK MRA Myeloma XI Trial
Authors: Charlotte Pawlyn, Faith E Davies, Gordon Cook, Heather McIntyre, Jeanine Richards, Sharon Jackson, Elizabeth Hodson, Catherine Olivier, Anna Hockaday, John R Jones, Martin F Kaiser, Matthew W. Jenner, Walter Martin Gregory, Ruth M de Tute, Roger G Owen, Mark Drayson, David A. Cairns, Gareth Morgan, Graham Jackson
Journal: Blood (2024)
Examining Disparities By Race, Ethnicity, and Socioeconomic Factors in Children and Young Adults with Relapsed Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group
Authors: John A Ligon, Deepa Bhojwani, Alice Dang, Lingyun Ji, Susan R Rheingold, Xinxin Xu, Meenakshi Devidas, John A. Kairalla, Mary Shago, Nyla A. Heerema, Andrew J. Carroll, Michael J. Borowitz, Brent L. Wood, Naomi J. Winick, William L. Carroll, Stephen P. Hunger, Elizabeth A. Raetz, Mignon L. Loh, Sumit Gupta, Lena E Winestone
Journal: Blood (2024)
Clinical Characteristics and Outcomes of Mixed Phenotype Acute Leukemia (MPAL): A Large Multi-Center Retrospective Study
Authors: Adam Julian Cohen-Nowak, Alexander Coltoff, Anand Ashwin Patel, Ehab L. Atallah, Mobachir El Kettani, John Wang, Emily Symes, Girish Venkataraman, Alexa Siddon, Emily Giever, Rory M. Shallis, Jessica Kaplan Altman, Kirsten Bell-Burdett, Talha Badar, Barina Aqil, Yasmin Abaza
Journal: Blood (2024)
Long-Term Follow-up of Patients with Aplastic Anemia Enrolled in Phase 2/3 Trials of Immunosuppressive Therapy Plus Romiplostim As a First-Line Treatment: Two-Year Interim Analysis
Authors: Kohei Hosokawa, Jong Wook Lee, Jun Ho Jang, Naoshi Obara, Masashi Sawa, Kensuke Usuki, Gaku Oshikawa, Masahiro Kizaki, Koji Nagafuji, Ting-An Lin, Hitoshi Hanamoto, Yeung-Chul Mun, Toshiro Kawakita, Kazunori Imada, June-Won Cheong, Sung-Soo Park, Takayuki Tabayashi, Masaru Gamou, Mami Shimizu, Kenta Murotani, Hirohito Yamazaki
Journal: Blood (2024)
Daratumumab Based Response Adapted Therapy for Older Adults with Newly Diagnosed Multiple Myeloma: Final Results of a Phase II Study
Authors: Rachid Baz, Mark B. Meads, Jongphil Kim, Ariel F. Grajales-Cruz, Brandon Blue, Sonila Toska, Xiaohong Zhao, Xiaofei Song, Praneeth Reddy Sudalagunta, Alexandra Achille, David R. Noyes, Samer Sansil, Sean J. Yoder, Ariosto Siqueira Silva, Omar Castaneda, Jose L. Ochoa-Bayona, Chaomei H. Zhang, Ciara Louise Freeman, Hien Liu, Doris K. Hansen, Taiga Nishihori, Melissa Alsina, Kenneth H. Shain
Journal: Blood (2024)
Myofibroblast to T-Zone Reticular Cell Ratio Identifies Unicentric Castleman Disease Lymph Nodes
Authors: Joshua D Brandstadter, Mechthild Lutge, Megan S Lim, Adam Bagg, Ira D. Miller, Michael V. Gonzalez, Bridget Austin, Salvatore F. Priore, Burkhard Ludewig, David C. Fajgenbaum, Ivan Maillard
Journal: Blood (2024)
Recurrent Amplification of Chromosome 7 in Murine AML with <i>Dnmt3a</i>R878H and <i>Npm1</i>cA Mutations Identifies <i>Gab2</i> As a Possible Therapeutic Target in AML
Authors: Michael H. Kramer, Stephanie N Richardson, Yang Li, Tiankai Yin, Nichole Helton, Daniel George, Michelle Cai, Sai Mukund Ramakrishnan, Christopher A Miller, Timothy J Ley
Journal: Blood (2024)
<i>KMT2C</i> Mutations Co-Operate with <i>KMT2A-MLLT1</i> Fusion to Inhibit Hematopoietic Differentiation in a Zebrafish Model of Infant Leukemia
Authors: Sarada Ketharnathan, Keon Collett, Anna Pawelko, Benno Orr, Sergey V Prykhozhij, Martin Hirst, Jason N. Berman
Journal: Blood (2024)
Utility of a Second Interim Maintenance Phase to Improve Outcomes for Pediatric Acute Lymphoblastic Leukemia: A Report from the Children's Oncology Group
Authors: Etan Orgel, Michael J. Burke, John A. Kairalla, Emily Hibbitts, Meenakshi Devidas, Michael J. Borowitz, Brent L. Wood, Nyla A. Heerema, Andrew J. Carroll, Kelly Maloney, Leonard A. Mattano, Anne Angiolillo, Eric C. Larsen, Wanda L. Salzer, David T. Teachey, Naomi J. Winick, William L. Carroll, Stephen P. Hunger, Elizabeth A. Raetz, Mignon L. Loh
Journal: Blood (2024)
Low Intensity Mini-Hypercvd (mHCVD), Inotuzumab Ozogamicin (Ino) with/without Blinatumomab (Blina) in Older Patients with Newly Diagnosed Philadelphia Negative B-Cell Acute Lymphoblastic Leukemia (B-ALL): 10 Years Update
Authors: Jayastu Senapati, Elias Jabbour, Nitin Jain, Fadi G. Haddad, Guillermo Garcia-Manero, Naval Daver, Tapan M. Kadia, Farhad Ravandi, Koji Sasaki, Courtney D. DiNardo, Koichi Takahashi, Rebecca Garris, Jovitta Jacob, Yesid Alvarado Valero, Guillermo Montalban-Bravo, Nicholas J. Short, Hagop Kantarjian
Journal: Blood (2024)
Exposure-Response Analysis and Quantitative Systems Pharmacology Modeling for Optimal RP2D Selection of AZD0486 in Follicular Lymphoma Patients
Authors: Xu (Sue) Zhu, Damilola Olabode, Massimo Lai, Cesar Pichardo-Almarza, Kevin Smart, Denise Brennan, David Sermer, Robin Lesley
Journal: Blood (2024)
<i>Dnmt3a</i> Mutant Hematopoietic Stem Cells Produce Hyperactive T Cells with Increased Alloimmune and Anti-Leukemic Activity
Authors: LaShanale Wallace, Mark Engelken, Jacquelyn A. Myers, John Harper, Brandi Clark, David Cullins, Jaquelyn T. Zoine, Raghuvaran Shanmugam, Stefan Schattgen, M. Paulina Velasquez, Heather Sheppard, Jeremy Chase Crawford, Paul G. Thomas, Esther A. Obeng
Journal: Blood (2024)
Leukemia Physician's Perspective on Transplant in Patients with <i>TP53</i> Mutated Acute Myeloid Leukemia
Authors: Yenny Alejandra Moreno Vanegas, Suhaib Younis Mohamed El Khatib, Brooke Hisrich, Alexander Coltoff, Rory M. Shallis, Anand Ashwin Patel, Jan Philipp Bewersdorf, Timothy S. Oh, Yasmin Abaza, Charles Foucar, Aaron D. Goldberg, Adam S. Duvall, Ehab L. Atallah, Mark R. Litzow, Talha Badar
Journal: Blood (2024)
Oncogenic CARD11 Mutations and Autonomous BCR Signaling Act As Functionally Equivalent Alternative Drivers in ABC-DLBCL
Authors: Janneke Eken, Fleur R.M. Havenaar, Edwin Quinten, Ruben A.L. De Groen, Julieta Sepulveda-Yanez, Joost S.P. Vermaat, Cornelis A.M. van Bergen, Hendrik Veelken
Journal: Blood (2024)
T/NK Cell-Associated Transcriptomic Profile Informs Response to FLT3 Inhibitors in Acute Myeloid Leukemia
Authors: Jacopo Nanni, Jayakumar Vadakekolathu, Lorenza Bandini, Marilena Ciciarello, Karyna Volkava, Samantha Bruno, Valentina Robustelli, Letizia Zannoni, Chiara Sartor, Gianluca Cristiano, Federico Zingarelli, Andrea Davide Romagnoli, Caterina Azzimondi, Federica Ardizzoia, Raffaele Ciruolo, Giovanni Marconi, Claudia Venturi, Ajsi Kanapari, Gaia Mazzocchetti, Giorgia Simonetti, Martina Ghetti, Nicoletta Testoni, Sarah Parisi, Stefania Paolini, Simona Soverini, Emanuela Ottaviani, Cristina Papayannidis, Michele Cavo, Sergio Rutella, Antonio Curti
Journal: Blood (2024)
Interim Analysis of Dara VRD in the Treatment of TE-NDMM Patients with Standard Risk Who Refused to Accept ASCT As First Line in China
Authors: Chengcheng Fu, Jing Wang, Song Jin, Lingzhi Yan, Jingjing Shang, Weiqin Yao, Xiaolan Shi, Zhi Yan, Depei Wu
Journal: Blood (2024)
Allogeneic Hematopoietic Stem Cell Transplantation Following CAR T Therapy in Relapsed/Refractory Acute Lymphoblastic Leukemia
Authors: Natalie Rafaeli, David Marin, Celina Ledesma, Nitin Jain, Priti Tewari, Issa F. Khouri, Amanda L. Olson, Gheath Alatrash, Nicholas J. Short, Elias Jabbour, Katy Rezvani, Amin M. Alousi, Uday Popat, Richard E. Champlin, Elizabeth J. Shpall, Partow Kebriaei
Journal: Blood (2024)
Understanding the Associations between High-Dose Methotrexate Pharmacokinetics and the Risk of Adverse Events in Children and Adolescents with Down Syndrome Associated High-Risk Acute Lymphoblastic Leukemia
Authors: Kate D. Westmoreland, Zachary L Taylor, Tamara P. Miller, Ashley Chavana, Karen R Rabin, Austin L Brown, Melanie Brooke Bernhardt, Eric S. Schafer, Maureen M. O'Brien, Sharon M. Castellino, Laura B. Ramsey
Journal: Blood (2024)
Lacutamab in Patients with Relapsed and/or Refractory Sézary Syndrome: Translational Analysis from the Tellomak Phase 2 Trial
Authors: Maxime Battistella, Alejandro A. Gru, Hélène Moins-Teisserenc, Martine Bagot, Youn-H H. Kim, Larisa J Geskin, Pablo L Ortiz-Romero, Ellen Kim, Neha Mehta-Shah, Olivier Dereure, Saskia Oro, Lubomir Sokol, Marie Beylot-Barry, Stéphane Dalle, Eric D. Jacobsen, Frederick Lansigan, Caroline Ram-Wolff, Michael S. Khodadoust, Pier Luigi Zinzani, Julien Viotti, David Magrez, Agnes Boyer Chammard, Constance Vagne, Flavien Carraguel, Laura Assante Miranda, Valentine Peri, Sivan Bokobza, Marie-Laure Thibult, Cécile Bonnafous, Florent Carrette, Pierluigi Porcu
Journal: Blood (2024)
Developing a Therapeutic Strategy for Targeting Metabolic Vulnerability of TET2 Mutant Leukemia
Authors: Xiaorong Gu, Yahan Zhang, Songa Bae, Dongxu Jiang, Nakisha D Williams, Daniel Vail, Simon Schlanger, Jill Durkin, Yvonne Parker, Daniel Lindner, Jaroslaw Maciejewski, Babal K. Jha
Journal: Blood (2024)
Blood-Based Proteomic Profiling Identifies Osmr As a Novel Biomarker
Authors: Hussein A. Abbas, Bofei Wang, Jennifer Marvin-Peek, Bin Yuan, Araceli Isabella Garza, Jessica Lynn Root, Andrea Arruda, Yiwei Liu, Courtney D. DiNardo, Tapan M. Kadia, Naval Daver, Philip L Lorenzi, Koji Sasaki, Steven M. Kornblau, Mark D. Minden, Farhad Ravandi, Hagop M. Kantarjian, Patrick K. Reville
Journal: Blood (2024)
Genetic Classification of Acute Myeloid Leukemia By Differential Long Noncoding RNA Expression
Authors: Saioa Arza-Apalategi, Daan Gilissen, Anne van der Grinten, Heuts Branco, Erik Van Den Akker, Marieke Griffioen, Joop H. Jansen, Joost H.A. Martens, Bert A. Van der Reijden
Journal: Blood (2024)
Treatment Outcomes in Acute Promyelocytic Leukemia Patients Using a Uniform ATRA + ATO Consolidation Therapy Regimen across All Risk Groups: A Single Centre Study from India
Authors: Reshma Benson, Arjun Kachhwaha, Paras Satadeve, Adamya Gupta, Karthik Kumar, Sashi Singh, Jhasaketan Nayak, Kavya Ronanki, Prisla Dalton, Bibhant Shah, Nikhil Nagpal, Uttam Kumar Nath
Journal: Blood (2024)
Inflammation-Based Scores Predict Survival after CD3xCD20 Bispecific T Cell Engagers in R/R LBCL
Authors: Giulia Magno, Kai Rejeski, Giulia Rappa, Sissi Kupf, Sophia Stock, Alessandra M. E. Holzem, Julia Katharina Scholz, Rebecca Wurm-Kuczera, Shimrit Harlev, Nadine Kutsch, Giuliano Filippini Velazquez, Stephanie Mayer, Maria Landwehr, Jamila Mammadova, Sandeep S. Raj, Roni Shouval, Fabian Mueller, Björn Chapuy, Ofrat Beyar-Katz, Udo Holtick, Christoph Schmidt, Hendrik Poeck, Gloria Iacoboni, Pere Barba, Ning Dong, Veit L. Buecklein, Marion Subklewe
Journal: Blood (2024)
Markers of Activated Coagulation Factor XII Are Inversely Associated with Progression of Atrial Fibrillation in the Race V Study
Authors: Magdolna Nagy, Vanessa Weberndoerfer, Jens Posma, Sander Van Kuijk, Bao-Oanh Nguyen, Hugo Ten Cate, Isabelle C Van Gelder, Harry Crijns, Michiel Rienstra, Henri M.H. Spronk
Journal: Blood (2024)
Brentuximab Vedotin-Based Regimens for Older Patients with Newly Diagnosed Classical Hodgkin Lymphoma - International, Multi-Center Real-World Experience
Authors: Efrat Luttwak, Swetha Kambhampati, Esther Drill, Nivetha Ganesan, Liron Hofstetter, Ronit Gurion, Shlomzion Aumann, Arnon Haran, Mika Geva, Marc Panossian, Robert Stuver, Paul A. Hamlin, Ariela Noy, Alex F. Herrera, Alison Moskowitz
Journal: Blood (2024)
Trends in All-Cause Mortality Rates in Patients with Follicular Lymphoma in the US before and during the COVID-19 Pandemic: A Retrospective Observational Study
Authors: Kim Linton, John N. Allan, Andrew S Park, Anthony W Wang, Summer Tran, Alex Mutebi, Zhijie Ding, Quan Chen, Tycel J. Phillips
Journal: Blood (2024)
Single Center Experience Combining Multiple Tools for Genetic Diagnosis of B-Cell Acute Lymphoblastic Leukemia
Authors: Gloria Hidalgo-Gomez, Bárbara Tazón-Vega, Carlos Palacio, Silvia Saumell, María Gabarrós-Subirà, Andres Jerez, Adoracion Blanco, Noemí Martínez-Morgado, Víctor Navarro Garces, Laura Murillo, Pablo Velasco, Thais Murciano, Cristina Díaz De Heredia, Francesc Bosch, Gemma Armengol, Margarita Ortega
Journal: Blood (2024)
Central Nervous System Involvement Does Not Worsen Survival in Hematologic or Molecular Relapse of Adult Acute Lymphoblastic Leukemia Patients - Retrospective Analysis By the Czech Leukemia Study Group for Life (CELL)
Authors: Stepan Hrabovsky, Cyril Salek, Frantisek Folber, Jan M Horacek, Tomas Szotkowski, Zdenek Koristek, Jozef Lukas, Tomas Arpas, Denisa Bakesova, Martin Cernan, Veronika Bergerova, Jiri Sramek, Jan Novak, Michael Doubek
Journal: Blood (2024)
Long-Term Safety and Efficacy of Autologous Hematopoietic Cell Transplantation for Patients with Progressive Systemic Sclerosis
Authors: Eleni Gavriilaki, Despina Mallouri, Ioannis Batsis, Zoi Bousiou, Anna Vardi, Nikolaos Spyridis, Georgios Karavalakis, Alkistis Kyra Panteliadou, Panagiotis Dolgyras, Christos Varelas, Vlasios I Alevizopoulos, Panagiotis Asteris, Panayiotis Vlachoyiannopoulos, Evangelia Yannaki, Damianos Sotiropoulos, Ioanna Sakellari
Journal: Blood (2024)
EP0042, a Dual FLT3 and Aurora Kinase Inhibitor: Final Results of Dose Escalation and Optimization Cohorts from a Phase I/IIa Study in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML), Chronic Myelomonocytic Leukemia (CMML) or Myelodysplastic Syndrome (MDS)
Authors: David Taussig, David C. de Leeuw, Mojca Jongen-Lavrencic, Jenny O'Nions, Thinzar Koko, Emma Searle, Geoff Fisher, Sue Brook, Hendrik-Tobias Arkenau, Ayan Aden Yusuf, Peter Tan
Journal: Blood (2024)
Real World Evidence of Second Line Therapy in Relapsed/Refractory Large B Cell Lymphoma: Spanish Multicenter Geltamo Study
Authors: Leyre Bento De Miguel, Mariana Bastos-Oreiro, Antonio Gutierrez, Cristina García, Almudena Cabero, Ana Jiménez Ubieto, Sonia González De Villambrosia, Alberto López, Santiago Browne, Blanca Sánchez-González, Paula Fernández-Caldas, Ana Muntañola, Belén Navarro, Ana Alarcón Tomás, Sandra Pérez, Ana Saus Carreres, Paola Villafuerte Gutiérrez, Eva Donato, Daniel García Belmonte, Jordina Rovira, Claudia Lozada, Hugo Daniel Luzardo Henríquez, Concepción Nicolás, Carlos Grande, Pau Abrisqueta, Alejandro Martín García-Sancho
Journal: Blood (2024)
Categorization and Impact of Bridging Therapy Prior to CAR T-Cell Infusion in Patients with Relapsed/Refractory Non-Hodgkin Lymphoma
Authors: Pranav Santapuram, Jason T Romancik, Jonathon B Cohen, Melissa Kives, Manali Rupji, Javier Pinilla-Ibarz, Kami J. Maddocks, Craig A. Portell, Joanna M. Rhodes, Brian K. Link
Journal: Blood (2024)
Targeting β-Catenin Protein Degradation in Refractory B-Cell Malignancies
Authors: Kadriye Nehir Cosgun, Mark E Robinson, Nikol Agadzhanian, Philipp Berning, David Fonseca-Arce, Etienne Leveille, Shalin Kothari, Matthew S. Davids, Julia Jellusova, Markus Müschen
Journal: Blood (2024)
Embryonic Ectoderm Development (EED) Inhibitor APG-5918 Demonstrates Robust Antitumor Activity in Preclinical Models of T-Cell Lymphomas (TCLs)
Authors: Zhiyan Liang, Yan Yin, Huanshan Guo, Baisong Li, Dajun Yang, Yifan Zhai
Journal: Blood (2024)
Familial Predisposition in Myeloproliferative Neoplasms: An NGS-Driven Analysis
Authors: Luca Di Marino, Francesco Ramundo, Tanja Malara, Monica Rossi, Roberto Maggi, Federica Fosso, Silvia Betti, Elena Rossi, Giuseppe Leone, Simona Sica, Valerio De Stefano, Patrizia Chiusolo
Journal: Blood (2024)
Safeguarding Lungs: Evaluating Pneumocystis Pneumonia Prophylaxis in Lymphoma Patients Receiving Rituximab-Inclusive Therapies
Authors: Anubhuti Sharma, Arundhati Sharma, Simranpreet Singh Daid, Vagisha Sharma, Akriti Agrawal, Adishwar Rao, Joyson Poulose
Journal: Blood (2024)
Deciphering Inflammasome Activation in Gaucher Macrophages and Its Role in the Development of Multiple Myeloma
Authors: Vivien Reinecke, Daniel Hofbauer, Jörg-Thomas Bittenbring, Christopher Lischer, Johannes Berges, Gina Nusser, Katrin Bitterer, Simon Voelkl, Dimitrios Mougiakakos, Andreas Mackensen, Heiko Bruns
Journal: Blood (2024)
Intense Monitoring of JAK2V617F and Wild-Type Hematopoiesis during IFNα Exposure to Dissect Its Mechanism of Action
Authors: Eli M Soyfer, Jianhong C Heidmann, Helen Huang, Yeowon Jung, Eshika Arora, Lauren Chen, Aanya Amin, Anaya Qamar, Angela G. Fleischman
Journal: Blood (2024)